News Archive

The content below is specific to Novartis Canada. To see all Novartis content, please visit the Novartis Global site.

2017

June

Media Release / Jun 22, 2017

Psoriasis Bodypainting Campaign

Psoriasis bodypainting campaign puts dermatologists ‘in their patients’ shoes’

Media Release / Jun 22, 2017

Novartis Top 10

Top 10 Novartis Facts and Figures

Media Release / Jun 20, 2017

Xolair®-CIU now covered

^PrXolair^® added to seven Canadian public drug plans to treat chronic idiopathic urticaria (hives)

Media Release / Jun 19, 2017

Combination treatment ^PrTafinlar^® (dabrafenib) plus ^PrMekinist^® (trametinib) approved by Health Canada to treat BRAF V600-positive metastatic non-small cell lung cancer (NSCLC) after prior systemic therapy¹

May

Media Release / May 11, 2017

Community Partnership Day

21 years of community service: Novartis takes part in annual Community Partnership Day in Canada

Media Release / May 09, 2017

Entresto™ in Ontario

Novartis heart failure treatment ^PrEntresto^™ (sacubitril/valsartan) now available to patients in Ontario through the public provincial drug plan

Media Release / May 03, 2017

New President

Montrealer Janice Murray named President of Novartis in Canada

March

Media Release / Mar 23, 2017

Entresto™ now covered in Quebec

Novartis heart failure treatment ^PrEntresto™ (sacubitril/valsartan) now covered by the Régie de l'assurance maladie du Québec (RAMQ)*

2016

August

Media Release / Aug 23, 2016

Novartis Kenya Mission

Novartis employees return from volunteer healthcare mission in rural Kenya

Media Release / Aug 17, 2016

Melanoma Through My Lens

Canadians with advanced skin cancer share their disease journey with launch of an empowering photo series: Melanoma Through My Lens

- TwitterTweet
- FacebookShare
- Share
  - Twitter
  - Facebook
  - Pinterest
  - LinkedIn
  - Google +
  - Email